Evidence map›Paper›PMID 35235168›Full record

ReviewCurrent neurology and neuroscience reports2022

Recent Advances in the Impact of Infection and Inflammation on Stroke Risk and Outcomes.

Stephanie E Oh, Neal S Parikh

Open access · bronzeAbstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. The Immunologic Underpinnings of Post-Stroke Depression.Biological psychiatry global open science · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Stroke-associated pneumonia with low PaOFrontiers in neurology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. DoFrontiers in nutrition · 2024
    Article
  13. The Role of Inflammation in Cardiovascular Disease.International journal of molecular sciences · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stephanie E OhClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, 420 E 70th Street, 4th floor, New York, NY, 10021, USA.
Neal S ParikhClinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, 420 E 70th Street, 4th floor, New York, NY, 10021, USA. nsp2001@med.cornell.edu.
Cornell University · US

Funding

Role of Liver Fibrosis in Cognitive Impairment and DementiaK23AG073524 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI PARIKH, NEAL S · 2021 to 2023
$585k
NIA NIH HHS K23 AG073524
6 · The paper itself

Abstract

purpose of the reviewInflammation is a key component in the pathogenesis of cerebrovascular diseases. In the past few years, the role of systemic infection and gut dysbiosis in modulating inflammation and stroke risk has been increasingly acknowledged. In this review, we synthesize contemporary literature on the effects of infection and inflammation on stroke risk and outcomes, with a focus on periodontal disease, COVID-19 infection, and gut dysbiosis. RECENT

findingsChronic and acute infections such as periodontitis and COVID-19 induce systemic inflammation that cause atherogenesis and increase cardiac injury and arrhythmias. These infections also directly injure the endothelium leading to worsened secondary inflammation after stroke. Gut dysbiosis engenders a pro-inflammatory state by modulating intestinal lymphocyte populations that can traffic directly to the brain. Additionally, post-stroke immune dysregulation creates a compounding feedback loop of further infections and gut dysbiosis that worsen outcomes. Recent advances in understanding the pathophysiology of how infection and dysbiosis affect the progression of stroke, as well as long-term recovery, have revealed tantalizing glimpses at potential therapeutic targets. We discuss the multidirectional relationship between stroke, infection, and gut dysbiosis, and identify areas for future research to further explore therapeutic opportunities.

Indexed as

COVID-19Gastrointestinal MicrobiomeStrokeDysbiosisHumansInflammationCOVID-19DysbiosisInfectionInflammationPeriodontitisStroke

Identifiers

PMID35235168
PMCPMC8889053
OpenAlexW4214813596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.